0001181431-13-049523.txt : 20130917 0001181431-13-049523.hdr.sgml : 20130917 20130917173703 ACCESSION NUMBER: 0001181431-13-049523 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130916 FILED AS OF DATE: 20130917 DATE AS OF CHANGE: 20130917 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sagent Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001369786 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 BUSINESS PHONE: 847-908-1604 MAIL ADDRESS: STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 FORMER COMPANY: FORMER CONFORMED NAME: Sagent Holding Co. DATE OF NAME CHANGE: 20090529 FORMER COMPANY: FORMER CONFORMED NAME: NHS PHARMACEUTICALS DATE OF NAME CHANGE: 20060720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YORDON JEFFREY CENTRAL INDEX KEY: 0001189013 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35144 FILM NUMBER: 131102182 4 1 rrd390716.xml X0306 4 2013-09-16 0 0001369786 Sagent Pharmaceuticals, Inc. SGNT 0001189013 YORDON JEFFREY C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 1 1 0 0 Chief Executive Officer Common Stock 2013-09-16 4 S 0 85813 20.0282 D 669036 D In connection with Sagent Pharmaceutical, Inc.'s (the "Issuer") registered offering, Jeffrey Yordon sold 85,813 shares of the Issuer's common stock, pursuant to an underwriting agreement, dated September 10, 2013, by and among the Issuer, the underwriters and the selling stockholders party thereto. Mr. Yordon's shares were sold at a price of $20.0282 per share, which is the price to the public ($21.25 per share) less the underwriting discounts and commissions ($1.2218 per share). /s/ Jeffrey Yordon 2013-09-17